Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?

Andrew Graeme Affleck, Hywel Williams

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1642-1643
    Number of pages2
    JournalArchives of Dermatology
    Issue number12
    Publication statusPublished - 15 Dec 2008


    • Evidence-Based Medicine
    • Humans
    • Immunosuppressive Agents
    • Isoxazoles
    • Male
    • Psoriasis
    • Randomized Controlled Trials as Topic
    • Young Adult

    Cite this